4Filed Aug 13, 8:00 PM ET

Pediatrix (MD) Director Shirley A. Weis Receives 472-Share Award

$MD · Pediatrix Medical Group, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Pediatrix (MD) Director Shirley A. Weis Receives 472-Share Award

What Happened
Shirley A. Weis, a director of Pediatrix Medical Group, received a grant of 472 restricted shares on 2026-08-12. The reported grant price is $26.50 per share, for a total award value of $12,508. This was an equity award (transaction code A), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (filed within the typical two-business-day window).
  • Price reported: $26.50 per share; total value: $12,508.
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Footnote: Shares are restricted grants under the Issuer’s Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award; shares will vest on May 7, 2027.
  • Transaction code: A = Award/Grant. No 10% owner indication or 10b5-1 plan noted.

Context
Restricted share grants to directors are typically part of regular compensation and intended to align long-term interests with shareholders; they do not represent an immediate cash inflow or market sale. Because these shares vest over time (here, on May 7, 2027), they act as a retention incentive rather than an immediate market signal.